Standardized low-resolution brain electromagnetic tomography does not improve EEG Alzheimer's disease assessment
Abstract: Highlights•First study, in any disease, to examine the added value of a 3D source localization method.•Largest prospective multi-center AD study comparing markers of slowing, complexity, and functional connectivity.•Thousands of QEEG markers analyzed with stringent control for multiple testing.•Highly significant associations between QEEG markers and MMSE scores.•No additional benefit of sLORETA over surface QEEG for AD assessment.
Loading